Evidence map›Paper›PMID 41180464›Full record

ArticleFrontiers in digital health2025

An AI-powered data curation and publishing virtual assistant: usability and explainability/causability of, and patient interest in the first-generation prototype.

Rutger van Mierlo, Wenjie Liang, Kerli Norak, Michaela Kargl, Mall Maasik, Anne-Lore Bynens, Markus Plass, Markus Kreuzthaler, Martin Benedikt, Laura Hochstenbach and 6 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rutger van MierloDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Wenjie LiangDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Kerli NorakDepartment of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
Michaela KarglDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Mall MaasikDepartment of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
Anne-Lore BynensClinical Data Science, Maastricht University Medical Centre (MUMC+), Maastricht, Netherlands.
Markus PlassDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Markus KreuzthalerInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Martin BenediktDepartment of Internal Medicine, Division of Cardiology, Medical University of Graz, Graz, Austria.
Laura HochstenbachDepartment of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
Arnoud van 't HofDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Remzi CelebiDepartment of Advanced Computing Sciences, Maastricht University, Maastricht, Netherlands.
Andre DekkerDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Isabelle de Zegherb!loba, Tervuren, Belgium.
Petros KalendralisDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
AIDAVA consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ensuring high quality and reusability of personal health data is costly and time-consuming. An AI-powered virtual assistant for health data curation and publishing could support patients to ensure harmonization and data quality enhancement, which improves interoperability and reusability. This formative evaluation study aimed to assess the usability of the first-generation (G1) prototype developed during the AI-powered data curation and publishing virtual assistant (AIDAVA) Horizon Europe project. Methods: In this formative evaluation study, we planned to recruit 45 patients with breast cancer and 45 patients with cardiovascular disease from three European countries. An intuitive front-end, supported by AI and non-AI data curation tools, is being developed across two generations. G1 was based on existing curation tools and early prototypes of tools being developed. Patients were tasked with ingesting and curating their personal health data, creating a personal health knowledge graph that represented their integrated, high-quality medical records. Usability of G1 was assessed using the system usability scale. The subjective importance of the explainability/causability of G1, the perceived fulfillment of these needs by G1, and interest in AIDAVA-like technology were explored using study-specific questionnaires. Results: A total of 83 patients were recruited; 70 patients completed the study, of whom 19 were unable to successfully curate their health data due to configuration issues when deploying the curation tools. Patients rated G1 as marginally acceptable on the system usability scale (59.1 ± 19.7/100) and moderately positive for explainability/causability (3.3-3.8/5), and were moderately positive to positive regarding their interest in AIDAVA-like technology (3.4-4.4/5). Discussion: Despite its marginal acceptability, G1 shows potential in automating data curation into a personal health knowledge graph, but it has not reached full maturity yet. G1 deployed very early prototypes of tools planned for the second-generation (G2) prototype, which may have contributed to the lower usability and explainability/causability scores. Conversely, patient interest in AIDAVA-like technology seems quite high at this stage of development, likely due to the promising potential of data curation and data publication technology. Improvements in the library of data curation and publishing tools are planned for G2 and are necessary to fully realize the value of the AIDAVA solution.

Indexed as

artificial intelligencecausabilitydata curationdata publishingexplainabilityinteroperabilityreusabilityusability

Identifiers

PMID41180464
PMCPMC12576891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.